P Zanoni*, K Steindl*, D Sengupta*, et. al. (2021). “Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype.†Genetics in Medicine, 1-10 (* Authors contributed equally),
2. G Yuan, N Flores, S Hausmann, S Lofgren, V Kharchenko, M Ibanez, D Sengupta, X Lu, I Czaban, D Azhibek, S Vicent, W Fischle, M Jaremko, B Fang, I Wistuba, K Chua, J Roth, J Minna, N Shao, L Jaremko, P Mazur & O Gozani (2021). “Elevated NSD3 histone methylation activity drives squamous cell lung cancer†Nature, 590 (7846), 504–508
3. W Li, W Tian, G Yuan, P Deng, D Sengupta, Z,Cheng, Y Cao, J Ren, Y Qin, Y Zhou, Y Jia, O Gozani, DJ Patel, Z Wang (2021). Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases. Nature, 590 (7846), 498-503.
4. B Shields, F Mahmoud, E Taylor, SD Byrum, D Sengupta, B Koss, G Baldini, S Ransom, K Cline, S Mackintosh, R Edmondson, S Shalin, and AJ Tackett (2017). “Indicators of responsiveness to immune checkpoint inhibitors.†Sci Rep, 7(1). 1-12.
5. D Sengupta, AJ Tackett (2016). “Proteomic Findings in Melanoma.†J Proteomics & Bioinform 9 (4).
6. D Sengupta, N Avaritt, S Shalin, A Tackett (2016). “Enhancer of zeste homolog 2 (EZH2) inhibition in metastatic melanoma promotes tumor regression in vivo.†Cancer Research 76 (14 Supplement), 1146- 1146.
7. D Sengupta, S Byrum, N Avaritt, L Davis, L Orr, S Mackintosh, S Shalin, A Tackett (2016). “Quantitative histone mass spectrometry identifies elevated histone H3 lysine 27 trimethylation in melanoma.†Molecular and Cellular Proteomics, 15(3), 765-775.
8. D Sengupta, A Kannan, M Kern, M Moreno, E Vural, B Stack, J Suen, A Tackett and L Gao (2015). “Disruption of BRD4 at H3K27Ac-enriched enhancer region correlates with decreased c-Myc expression in Merkel cell carcinoma.†Epigenetics, 10(6), 460-466.
9. D Sengupta, N Avaritt, A Tackett (2015). “EZH2 Overexpression in Malignant Melanoma Represses E- cadherin and Promotes Invasion.†The FASEB Journal 29 (1 Supplement), 877.8.
10. U Udensi, A Tackett, S Byrum, N Avaritt , D Sengupta, et al. (2014). “Proteomics-Based Identification of Differentially Abundant Proteins from Human Keratinocytes Exposed to Arsenic Trioxide.†J Proteomics Bioinform 7 (7): 166-178.
11. N Avaritt, F Mahmoud, D Sengupta, I Makhoul, L Hutchins, A Tackett (2014). “Role of the EZH2 histone ethyltransferase in melanoma.†Pigment Cell & Melanoma Research 27 (6).
12. N Avaritt, M Fade, M Reynolds, D Sengupta, I Makhoul, S Shalin, A Tackett (2013). “Cutaneous Melanoma: Molecular Mechanisms and Current Therapeutic Approaches.†Melanoma: Molecular Biology, Risk Factors and Treatment Options Chapter 6 pp.137-154. Hauppauge, New York: Nova Science Publishers.
PEER-REVIEWED PUBLICATIONS